thiazoles has been researched along with Viremia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arzumanyan, A; Clayton, MM; Feitelson, MA; Goldmann, S; Li, J; Liu, B; Ren, Q; Schinazi, RF; Wang, Z; Wu, G; Zhang, F; Zhang, Y | 1 |
| Arastéh, K; Bhagani, S; Dieterich, D; Guardiola, JM; Ingiliz, P; Jain, MK; Kort, J; Laguno, M; Manero, M; Nelson, M; Rockstroh, JK; Soriano, V; Stern, JO; Tural, C; Vinisko, R | 1 |
| Carr, A; Cooper, DA; Kelleher, AD; Zaunders, J | 1 |
| Ho, DD; Leonard, JM; Markowitz, M; Neumann, AU; Perelson, AS | 1 |
| Cohen, J | 1 |
| Chang, HE | 1 |
2 trial(s) available for thiazoles and Viremia
| Article | Year |
|---|---|
Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.
Topics: Adolescent; Adult; Aged; Aminoisobutyric Acids; Anti-Retroviral Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Leucine; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Quinolines; Recombinant Proteins; Ribavirin; Thiazoles; Treatment Outcome; Viral Load; Viremia; Young Adult | 2015 |
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, Differentiation; Antiviral Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Immune System; Leukocyte Common Antigens; Lymphocyte Activation; Membrane Glycoproteins; N-Glycosyl Hydrolases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ritonavir; RNA, Viral; Thiazoles; Valine; Viremia | 1996 |
4 other study(ies) available for thiazoles and Viremia
| Article | Year |
|---|---|
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.
Topics: Animals; Antiviral Agents; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Lamivudine; Male; Mice; Mice, Nude; Microbial Sensitivity Tests; Primary Cell Culture; Pyridines; Pyrimidines; Thiazoles; Viral Core Proteins; Viremia; Virion; Virus Replication | 2013 |
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
Topics: Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Survival; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Kinetics; Models, Biological; Regression Analysis; Ritonavir; RNA, Viral; Thiazoles; Valine; Viremia; Virion; Virus Replication | 1996 |
Results on new AIDS drugs bring cautious optimism.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; RNA, Viral; Thiazoles; Valine; Viremia | 1996 |
Conference looks at HIV drug resistance.
Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine | 1995 |